We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Intralesional Antimony for Bolivian Cutaneous Leishmaniasis

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01300975
First Posted: February 23, 2011
Last Update Posted: July 6, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
The Alfred Berman Foundation for Medical Research
Universidad Mayor de San Simón
Hospital Dermatológico de Jorochito
Proyecto OSCAR
Information provided by (Responsible Party):
Fundacion Nacional de Dermatologia